Coffee Consumption and Lower Advanced Fibrosis Risk in MASLD and MetALD: Dose–dependent Association With Heightened Protection Among Moderate Alcohol Users

Journal of Clinical and Experimental Hepatology · Published 2026-07-13 · DOI 10.1016/j.jceh.2026.103612

Free full text

Authors (4)

Sebastian Niezen, Markos Kalligeros, Manaav K.S. Mehta, Elliot B. Tapper

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Niezen, S., Kalligeros, M., Mehta, M., et al. (2026). Coffee Consumption and Lower Advanced Fibrosis Risk in MASLD and MetALD: Dose–dependent Association With Heightened Protection Among Moderate Alcohol Users. Journal of Clinical and Experimental Hepatology. https://doi.org/10.1016/j.jceh.2026.103612

Related articles